The Compliant Brand Manager

Best pick: Focus on Vuse and NJOY PMTA-authorized products with expanding flavor portfolios.

Your challenge is competing against 6,000+ unauthorized products with 45 authorized ones. The Glas fruit authorization may be your turning point — but the pace of FDA's PMTA pipeline determines whether you can match the gray market's flavor variety before state-level enforcement eliminates your competitors for you.

The Industry Investor

Best pick: Monitor BAT (Vuse) and Altria (NJOY) for compliant market growth; watch nicotine pouch segment (ZYN/on!) for diversification.

The market's structural divide creates a unique investment thesis: compliant brands have regulatory moats but limited growth, while gray market brands have growth but existential regulatory risk. The Glas authorization may signal which way the wind blows.

The Retailer / Distributor

Best pick: Audit your product mix against PMTA registry states; prepare for state-level disposable bans.

If you operate in PMTA registry states, you face inventory culling. In non-registry states, you face the gray market's price competition. Either way, diversifying into nicotine pouches and FDA-authorized products is your hedge against regulatory disruption.

The Consumer Advocate

Best pick: Track FDA's PMTA pipeline and state-level consumer access data.

The 45 authorized products represent a fraction of what consumers actually use. The gap between regulatory authorization and market reality means most adult vapers are using unauthorized products. Advocacy should focus on accelerating the PMTA pipeline and ensuring authorized products meet consumer preferences.